Rare diseases
Investigational molecules
Locations
Phase 3 Extension Trial Evaluating Long‑Term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity
FinlandRandomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease
FinlandContraceptive efficacy, safety and tolerability of drospirenone 4 mg (LPRI‑CF113) in healthy women of reproductive age over 13 cycles
FinlandEfficacy and Safety of ALKS 2680 and Alixorexton in Adults with Narcolepsy Type 1
FinlandPhase 3 Randomized Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1
FinlandOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
FinlandPhase 2a Study of Safety, Tolerability and Efficacy of Intranasal Cenegermin in Adults with Moderate to Severe Subacute Traumatic Brain Injury
FinlandA study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness
FinlandStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
FinlandStudy of GSK5764227 alone and in combination for patients with previously treated advanced gastrointestinal tumors that cannot be removed by surgery or have spread
FinlandStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
FinlandStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
FinlandTell us about your condition – we search every trial in Europe and connect you with the right site.
